维普中文期刊产品整合服务
36篇 您的检索式:作者名="Engert V"
    题名 作者 年代 出处 被引量
1Associations between neuroendocrine responses to the insulin tolerancetest and patient characteristics in chronic fatigue syndrome显示文摘Gaab J Engert V Heitz V 0,,04:1
2Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma:10 years of follow-up of the GHSG HD9 study显示文摘Engert A Diehl V Franklin J 2009J Clin Oncol2009,27,:1
3Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization 显示文摘Reiser M Josting A Draube A Mapara MY Scheid C Chemnitz J Tesch H Wolf J Diehl V Sohngen D Engert A 1999Bone Marrow Transplant1999,23,12:1
4Dexa-BEAM is not effective in patients with relapsed or resistant aggressive high-grade non-Hodgkin's lymphoma 显示文摘Reiser M Josting A Dias Wickramanayake P Draube A Scheid C Tesch H Wolf J Diehl V Engert A 1999Leuk Lymphoma1999,33,34:1
5Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma:10 years of follow-up of the GHSG HD9 study显示文摘Engert A Diehl V Franklin J 2009J Clin Oncol2009,27,27:1
6Monoclonal anti-CD20 antibody rituximab for treatment of CD20 positive Hodgkin's lymphoma: the German experience (abstract) 显示文摘Rehwald U Engert A Diehl V 2000Blood2000,96,:1
7Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma:10 years of follow-up of the GHSG HD9 Study显示文摘Engert A Diehl V Franklin J 2009J Clin Oncol2009,27,27:1
8A national scale au- thentication infrastructure 显示文摘Butley R Welch V Engert D 2000IEEE Computer2000,33,12:1
9Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome显示文摘Gaab J Engert V Heitz V 2004J Psychosom Res2004,56,:1
10Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study显示文摘Engert A Diehl V Franklin J 2009J Clin Oncol2009,27,27:1
11Treatment of advanced Hodgkin's lymphoma:stand and experimental approaches 显示文摘Engert A Wolf J Diehl V 1999Semin Hemalot1999,36,3:1
12Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin' s lymphoma: 10 years of follow-up of the GHSG HD9 study显示文摘Engert A Diehl V Franklin J 2009I Clin Oncol2009,27,27:1
13A National-Scale Authentication Infrastructure显示文摘Butler D Welch V Engert D 2000Journal of Computer2000,33,12:1
14Escalated - dose BEACOPP in the treatment of patients with advanced - stage Hodgkin's lymphoma : 10 years of follow -up of the GHSG HD9 study显示文摘Engert A Diehl V Franklin J 2009J Clin Oncol2009,27,27:1
15A phase-Ⅰ study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma显示文摘Engert A Diehl V Schnell R 1997Blood1997,89,2:1
16A national-scale Authentication Infrastructure显示文摘Butler R Welch V Engert D 2000IEEE Computer2000,33,12:1
17Female fertility after cytotoxic therapy-protection of ovarian function during chemotherapy of malignant and non-malignant disease显示文摘Mattle V Behringer K Engert A 0,,66:1
18Hodgkin's lymphoma in the elderly:a different disease in patients over 60显示文摘Klimm B Diehl V Engert A 2007Oncology(Williston Park)2007,21,8:1
19Will it be another 20 years before Hodg!dn lymphoma patients benefit from BEACOPP therapy? 显示文摘DIEHL V ENGERT A 2006Nat Clin Pract Oncol2006,3,5:1
20Psychological, endocrine and neural responses to social evaluation in subclinical depression 显示文摘Dedovic K Dtmhesne A Engert V 2014Soc Cogn Affect Neurosci2014,9,10:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费